Quantrx Biomedical Corp financial data

Symbol
QTXB on OTC
Location
P.O. Box 4960, Tualatin, OR
State of incorporation
NV
Fiscal year end
December 31
Former names
AFEM MEDICAL CORP (to 2/17/2006), ATHENA MEDICAL CORP (to 5/20/1997)
Latest financial report
10-Q - Q3 2022 - Nov 14, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -100 % +1.32%
Return On Equity 9.51 % -10.2%
Return On Assets -4.76K % -592%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.7M shares
Common Stock, Shares, Outstanding 78.7M shares 0%
Common Stock, Value, Issued 787K USD 0%
Weighted Average Number of Shares Outstanding, Basic 78.7M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Costs and Expenses 44.3K USD -3.47%
Operating Income (Loss) -44.3K USD +3.47%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -261K USD +0.79%
Net Income (Loss) Attributable to Parent -261K USD +0.79%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.88K USD -81.6%
Assets, Current 5.38K USD -74.4%
Assets 5.38K USD -74.4%
Accounts Payable, Current 16.5K USD -12.2%
Liabilities 2.85M USD +9.41%
Retained Earnings (Accumulated Deficit) -52.6M USD -0.5%
Stockholders' Equity Attributable to Parent -2.84M USD -10.1%
Liabilities and Equity 5.38K USD -74.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 78.7M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30 USD +99.6%
Preferred Stock, Shares Authorized 25M shares 0%
Additional Paid in Capital 48.9M USD 0%
Interest Expense 216K USD -0.22%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%